千红制药
(002550)
| 流通市值：45.15亿 | | | 总市值：63.48亿 |
| 流通股本：9.10亿 | | | 总股本：12.80亿 |
| 报告期 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 464,690,328.84 | 425,168,313.78 | 470,466,348.14 | 409,256,667.51 |
| 应收票据及应收账款 | 277,466,090.84 | 388,878,251.09 | 500,961,515.29 | 571,044,560.65 |
| 其中：应收票据 | 6,045,699.4 | 8,640,265.46 | 11,365,435.29 | 5,964,118.84 |
| 应收账款 | 271,420,391.44 | 380,237,985.63 | 489,596,080 | 565,080,441.81 |
| 应收款项融资 | 23,424,466.7 | 60,457,646.93 | 58,232,949.65 | 61,821,179.44 |
| 预付款项 | 31,431,010.55 | 19,941,144.1 | 42,853,024.25 | 27,670,972.28 |
| 其他应收款合计 | 17,861,886.24 | 4,226,283.89 | 3,832,062.66 | 2,484,942.53 |
| 存货 | 674,946,988.77 | 765,075,344.75 | 709,033,420.43 | 536,483,390.67 |
| 其他流动资产 | 573,527.76 | 328,933.58 | 16,762,010.78 | 11,046,535.55 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 1,528,494,252.73 | 1,712,319,838.61 | 1,910,450,658.85 | 1,687,284,119.39 |
| 非流动资产: | | | | |
| 债权投资 | 279,268,687.67 | 247,930,937.49 | 204,776,076.87 | 151,437,465.76 |
| 长期股权投资 | 2,892,232.31 | 2,806,795.41 | 4,465,091.69 | 5,344,460.8 |
| 固定资产 | 508,870,129.88 | 536,460,137.84 | 547,793,283.35 | 562,286,283.46 |
| 在建工程 | 53,316,208.38 | 59,424,776.14 | 63,249,041.22 | 54,101,642.87 |
| 无形资产 | 91,368,706.99 | 97,460,017.03 | 99,131,667.97 | 100,861,453.7 |
| 开发支出 | 55,576,955.12 | 52,272,954.37 | 41,512,245.56 | 37,671,969.51 |
| 商誉 | 11,135,053.57 | 11,135,053.57 | 11,135,053.57 | 11,135,053.57 |
| 长期待摊费用 | 19,897,685.51 | 20,785,606.88 | 21,698,310.5 | 22,655,648.15 |
| 递延所得税资产 | 96,501,662.29 | 97,710,303.38 | 97,621,904.29 | 101,487,331.27 |
| 其他非流动资产 | 90,900,325 | 85,615,410.21 | 64,425,960 | 71,673,060 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 1,209,727,646.72 | 1,211,601,992.32 | 1,155,808,635.02 | 1,118,654,369.09 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 2,738,221,899.45 | 2,923,921,830.93 | 3,066,259,293.87 | 2,805,938,488.48 |
| 流动负债: | | | | |
| 短期借款 | 20,021,666.67 | 300,551,734.46 | 300,826,838.54 | 100,095,428.67 |
| 应付票据及应付账款 | 35,507,060.63 | 51,032,658.44 | 68,175,101.09 | 45,972,064.61 |
| 应付账款 | 35,507,060.63 | 51,032,658.44 | 68,175,101.09 | 45,972,064.61 |
| 合同负债 | 3,173,548.31 | 28,107,576.75 | 2,365,776.87 | 15,580,139.86 |
| 应付职工薪酬 | 36,090,956.95 | 23,444,477.28 | 26,685,680.14 | 43,058,714.33 |
| 应交税费 | 22,028,025.03 | 14,705,589.8 | 10,086,315.56 | 2,796,423.68 |
| 其他应付款合计 | 8,008,879.82 | 7,429,138.05 | 7,037,707.96 | 10,261,115.04 |
| 其他流动负债 | 46,328,578.61 | 45,102,055.4 | 42,019,637.97 | 60,455,579.18 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 171,158,716.02 | 470,373,230.18 | 457,197,058.13 | 278,219,465.37 |
| 非流动负债: | | | | |
| 递延收益 | 83,396,383.9 | 85,369,430.65 | 87,379,977.4 | 89,353,024.15 |
| 递延所得税负债 | 4,391,497.62 | 4,580,238.74 | 4,768,979.87 | 4,957,720.99 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 87,787,881.52 | 89,949,669.39 | 92,148,957.27 | 94,310,745.14 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 258,946,597.54 | 560,322,899.57 | 549,346,015.4 | 372,530,210.51 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 1,279,800,000 | 1,279,800,000 | 1,279,800,000 | 1,279,800,000 |
| 资本公积 | 40,067,587.24 | 36,288,651.51 | 36,288,651.51 | 36,288,651.51 |
| 减:库存股 | 30,093,633.31 | 30,093,633.31 | - | - |
| 其他综合收益 | -1,630,468.21 | -474,497.46 | -109,628.3 | -64,801.18 |
| 盈余公积 | 274,113,896.47 | 274,113,896.47 | 274,113,896.47 | 274,113,896.47 |
| 未分配利润 | 905,095,590.37 | 826,266,320.35 | 946,163,331.11 | 860,216,483.41 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 2,467,352,972.56 | 2,385,900,737.56 | 2,536,256,250.79 | 2,450,354,230.21 |
| 少数股东权益 | 11,922,329.35 | -22,301,806.2 | -19,342,972.32 | -16,945,952.24 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 2,479,275,301.91 | 2,363,598,931.36 | 2,516,913,278.47 | 2,433,408,277.97 |
| 负债和股东权益合计 | 2,738,221,899.45 | 2,923,921,830.93 | 3,066,259,293.87 | 2,805,938,488.48 |
| 公告日期 | 2023-10-25 | 2023-07-22 | 2023-04-15 | 2023-04-15 |
| 审计意见(境内) | | | | 标准无保留意见 |